| Bioactivity | 5-Bromo-3-phenyl salicylic acid is a selective inhibitor for human 20α-hydroxysteroid dehydrogenase (AKR1C1) with Ki of 140 nM[1]. |
| Target | Ki: 140 nM (AKR1C1), 1.97 μM (AKR1C2), 21 μM (AKR1C3) |
| CAS | 99514-99-5 |
| Formula | C13H9BrO3 |
| Molar Mass | 293.11 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. El-Kabbani O, et al., Structure-guided design, synthesis, and evaluation of salicylic acid-based inhibitors targeting a selectivity pocket in the active site of human 20alpha-hydroxysteroid dehydrogenase (AKR1C1). J Med Chem. 2009 May 28;52(10):3259-64. |
5-Bromo-3-phenyl salicylic acid
CAS: 99514-99-5 F: C13H9BrO3 W: 293.11
5-Bromo-3-phenyl salicylic acid is a selective inhibitor for human 20α-hydroxysteroid dehydrogenase (AKR1C1) with Ki of
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.